Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Levetiracetam ER by AgeneBio for Mild Cognitive Impairment: Likelihood of Approval
Levetiracetam ER is under clinical development by AgeneBio and currently in Phase III for Mild Cognitive Impairment. According to GlobalData,...
Data Insights
Levetiracetam ER by AgeneBio for Psychosis: Likelihood of Approval
Levetiracetam ER is under clinical development by AgeneBio and currently in Phase II for Psychosis. According to GlobalData, Phase II...